SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Sax P. E.) "

Sökning: WFRF:(Sax P. E.)

  • Resultat 1-2 av 2
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Borges, A. H., et al. (författare)
  • Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials
  • 2016
  • Ingår i: Clinical Infectious Diseases. - : Oxford University Press (OUP). - 1058-4838 .- 1537-6591. ; 63:2, s. 268-280
  • Tidskriftsartikel (refereegranskat)abstract
    • Background. Previous studies suggest that nonnucleoside reverse-transcriptase inhibitors (NNRTIs) cause faster virologic suppression, while ritonavir-boosted protease inhibitors (PI/r) recover more CD4 cells. However, individual trials have not been powered to compare clinical outcomes. Methods. We searched databases to identify randomized trials that compared NNRTI-vs PI/r-based initial therapy. A meta-analysis calculated risk ratios (RRs) or mean differences (MDs), as appropriate. Primary outcome was death or progression to AIDS. Secondary outcomes were death, progression to AIDS, and treatment discontinuation. We calculated RR of virologic suppression and MD for an increase in CD4 cells at week 48. Results. We included 29 trials with 9047 participants. Death or progression to AIDS occurred in 226 participants in the NNRTI arm and in 221 in the PI/r arm (RR, 1.03; 95% confidence interval, .87-1.22; 12 trials; n = 3825), death in 205 participants in the NNRTI arm vs 198 in the PI/r arm (1.04; 0.86-1.25; 22 trials; n = 8311), and progression to AIDS in 140 participants in the NNRTI arm vs 144 in the PI/r arm (1.00; 0.80-1.25; 13 trials; n = 4740). Overall treatment discontinuation (1.12; 0.93-1.35; 24 trials; n = 8249) and from toxicity (1.21; 0.87-1.68; 21 trials; n = 6195) were comparable, but discontinuation due to virologic failure was more common with NNRTI (1.58; 0.91-2.74; 17 trials; n = 5371). At week 48, there was no difference between NNRTI and PI/r in virologic suppression (RR, 1.03; 0.98-1.09) or CD4(+) recovery (MD, -4.7 cells; -14.2 to 4.8). Conclusions. We found no difference in clinical and viro-immunologic outcomes between NNRTI-and PI/r-based therapy.
  •  
2.
  • Schönfeld, B., et al. (författare)
  • Local order in Cr-Fe-Co-Ni : Experiment and electronic structure calculations
  • 2019
  • Ingår i: Physical Review B. - : American Physical Society. - 2469-9950 .- 2469-9969. ; 99:1
  • Tidskriftsartikel (refereegranskat)abstract
    • A quenched-in state of thermal equilibrium (at 723 K) in a single crystal of Cr-Fe-Co-Ni close to equal atomic percent was studied. Atom probe tomography revealed a single-phase state with no signs of long-range order. The presence of short-range order (SRO) was established by diffuse x-ray scattering exploiting the variation in scattering contrast close to the absorption edges of the constituents: At the incoming photon energies of 5969, 7092, and 8313 eV, SRO maxima that result from the linear superposition of the six partial SRO scattering patterns, were always found at X position. Electronic structure calculations showed that this type of maximum stems from the strong Cr-Ni and Cr-Co pair correlations, that are furthermore connected with the largest scattering contrast at 5969 eV. The calculated effective pair interaction parameters revealed an order-disorder transition at approximately 500 K to a L12-type (Fe,Co,Ni)3Cr structure. The calculated magnetic exchange interactions were dominantly of the antiferromagnetic type between Cr and any other alloy component and ferromagnetic between Fe, Co, and Ni. They yielded a Curie temperature (TC) of 120 K, close to experimental findings. Despite the low value of TC, the global magnetic state strongly affects chemical and elastic interactions in this system. In particular, it significantly increases the ordering tendency in the ferromagnetic state compared to the paramagnetic one.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-2 av 2

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy